FiberCell Systems offers hollow fiber bioreactor systems to academic and biotechnology markets. The company’s bioreactors utilize new, state-of-the-art filtration rates that offer many advantages over conventional cell culture methods, and are used by NASA at the International Space Station and endorsed by the European Medicines Agency.

FiberCell developed and patented a novel method for generating gas delivery to hollow fiber cartridges. Instead of passively exchanging gas with a medium and flowing that medium through the cartridge, it delivers alternating amounts of medium and gas directly to the interior of the reactor. Rather than using pumps, gravity feed is utilized to circulate the medium in both directions. A device using these technologies would be an entirely new concept in bioreactor operating principles. This was the subject of the company’s MIPS project.